Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Hepatoportal sclerosis (obliterative portal venopathy) and nodular regenerative hyperplasia in a patient with myasthenia gravis: A case report and review of the published work.

Agrawal M, Rahmani R, Nakkala K, Fiel MI, Schiano T.

Hepatol Res. 2013 Sep;43(9):999-1003. doi: 10.1111/hepr.12045. Epub 2013 May 15.

PMID:
23675894
2.
3.

Noncirrhotic portal hypertension.

Rajekar H, Vasishta RK, Chawla YK, Dhiman RK.

J Clin Exp Hepatol. 2011 Sep;1(2):94-108. doi: 10.1016/S0973-6883(11)60128-X. Epub 2011 Nov 9. Review.

4.

[Non-cirrhotic portal hypertension: rare cause of upper gastrointestinal bleeding].

Schouten JN, Verheij J, Janssen HL.

Ned Tijdschr Geneeskd. 2010;154:A1276. Dutch.

PMID:
20456763
5.

Obliterative portal venopathy: a clinical and histopathological review.

Aggarwal S, Fiel MI, Schiano TD.

Dig Dis Sci. 2013 Oct;58(10):2767-76. doi: 10.1007/s10620-013-2736-4. Epub 2013 Jun 29. Review.

PMID:
23812828
6.

Portal hypertension secondary to azathioprine in myasthenia gravis.

Fonseca V, Havard CW.

Postgrad Med J. 1988 Dec;64(758):950-2.

7.

Nodular regenerative hyperplasia with portal hypertension in a patient with myasthenia gravis.

Eliakim R, Ligumsky M, Jurim O, Shouval D.

Am J Gastroenterol. 1987 Jul;82(7):674-6.

PMID:
3496785
8.

Obliterative portal venopathy without portal hypertension: an underestimated condition.

Guido M, Sarcognato S, Sonzogni A, Lucà MG, Senzolo M, Fagiuoli S, Ferrarese A, Pizzi M, Giacomelli L, Colloredo G.

Liver Int. 2016 Mar;36(3):454-60. doi: 10.1111/liv.12936. Epub 2015 Sep 6.

PMID:
26264219
9.

Anticoagulant therapy for nodular regenerative hyperplasia in a HIV-infected patient.

Bihl F, Janssens F, Boehlen F, Rubbia-Brandt L, Hadengue A, Spahr L.

BMC Gastroenterol. 2010 Jan 18;10:6. doi: 10.1186/1471-230X-10-6.

10.
11.

Prevalence and clinical significance of nodular regenerative hyperplasia in liver biopsies.

Barge S, Grando V, Nault JC, Broudin C, Beaugrand M, Ganne-Carrié N, Roulot D, Ziol M.

Liver Int. 2016 Jul;36(7):1059-66. doi: 10.1111/liv.12974. Epub 2015 Oct 19.

PMID:
26415006
12.

Clinical analysis of 15 cases of liver nodular regenerative hyperplasia.

Guo T, Qian J, Zhu L, Zhou W, Zhu F, Sun G, Fang X.

Cell Biochem Biophys. 2012 Nov;64(2):115-21. doi: 10.1007/s12013-012-9379-5.

PMID:
22707296
14.

Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV.

Schiano TD, Kotler DP, Ferran E, Fiel MI.

Am J Gastroenterol. 2007 Nov;102(11):2536-40. Epub 2007 Jul 19.

PMID:
17640321
15.

Nodular regenerative hyperplasia of the liver: an under-recognized cause of portal hypertension in hematological disorders.

Al-Mukhaizeem KA, Rosenberg A, Sherker AH.

Am J Hematol. 2004 Apr;75(4):225-30. Review.

16.

Diagnostic problems in nodular regenerative hyperplasia (nodular transformation) of the liver. Review of the literature and report of two cases.

Trauner M, Stepan KM, Resch M, Ebner F, Pristautz H, Klimpfinger M.

Z Gastroenterol. 1992 Mar;30(3):187-94. Review.

PMID:
1590015
17.

Nodular regenerative hyperplasia of the liver: case report of a 13-year-old girl and review of the literature.

Trenschel GM, Schubert A, Dries V, Benz-Bohm G.

Pediatr Radiol. 2000 Jan;30(1):64-8. Review.

PMID:
10663513
18.

Hepatoportal sclerosis in childhood: a mimic of extrahepatic portal vein obstruction.

Carson JA, Tunell WP, Barnes P, Altshuler G.

J Pediatr Surg. 1981 Jun;16(3):291-6.

PMID:
7252729
19.

Noncirrhotic portal hypertension: another cause of liver disease in HIV patients.

Mendizabal M, Craviotto S, Chen T, Silva MO, Reddy KR.

Ann Hepatol. 2009 Oct-Dec;8(4):390-5.

PMID:
20009143
20.

Portal Hypertension, Nodular Regenerative Hyperplasia of the Liver, and Obstructive Portal Venopathy due to Metastatic Breast Cancer.

Turk AT, Szabolcs MJ, Lefkowitch JH.

Case Rep Pathol. 2013;2013:826284. doi: 10.1155/2013/826284. Epub 2013 Jul 31.

Supplemental Content

Support Center